Risk factors and risk-stratified prevention of periprosthetic fractures after hip arthroplasty in patients aged ≥80 years: A retrospective cohort study with prospective validation.

Xulin Chen, Zhifeng Yuan

Journal: Medicine 2026;105(6):e47521

PMID: 41650033

Abstract

Periprosthetic fractures (PPFs) are a serious complication after hip arthroplasty in very elderly patients. This study aimed to identify risk factors, develop a predictive model, and explore whether risk-stratified interventions are associated with lower PPF incidence. Patients aged ≥80 years undergoing hip arthroplasty for intertrochanteric fractures between April 2021 and May 2024 were retrospectively analyzed to identify independent risk factors for PPF within 12 months using multivariate logistic regression. A predictive model was developed and internally validated. Subsequently, 2 consecutive cohorts (conventional care vs risk-stratified intervention) were compared in a prospective non-randomized design. The intervention group received targeted measures addressing identified risk factors (gender-specific fall prevention, early anti-osteoporosis therapy with Qianggu Capsules and calcium, surgical optimization for cementless prostheses, and enhanced monitoring for prosthesis stability). Primary outcomes were 12-month PPF incidence and bone mineral density (BMD) changes. Independent risk factors were female sex, osteoporosis, cementless prosthesis, and prosthesis loosening. The predictive model showed good discrimination (area under the curve 0.874). In the prospective comparison, PPF incidence was lower in the risk-stratified intervention group than in the conventional care group (1.4% vs 10.0%, P = .029), with greater improvements in femoral neck and greater trochanter BMD (both P < .001). Female sex, osteoporosis, cementless prosthesis use, and prosthesis loosening were independently associated with higher PPF risk in very elderly patients. A risk-stratified intervention protocol was associated with reduced 12-month PPF incidence and improved BMD, suggesting potential clinical benefit of personalized preventive strategies.

Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, Inc.

Address: The First People's Hospital of Jingdezhen, Zhushan District, Jingdezhen City, Jiangxi Province, P.R. China.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.